Email Page Print Page

SEC Filings and Financial Information

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQBDSI
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventOct 12, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 6, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 22, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 12, 2017View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderSep 5, 2017View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KSep 1, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 29, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 10, 2017View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionAug 9, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventAug 1, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJul 18, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 18, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 23, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 21, 2017View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-53
Top News
Oct 12, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that it has entered into a...

Oct 6, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) participated in a round table meeting convened this week in Washington, D.C. by the U.S. Department of Health and Human Services (HHS) to...

Sep 19, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, Vice Chairman, President and Chief Executive Officer, will present at two upcoming healthcare conferences....

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com